Christopher Vakoc
Professor
Alan and Edith Seligson Professor of Cancer Research
Cancer Center Deputy Director of Research
M.D., Ph.D., University of Pennsylvania, 2007
vakoc@cshl.edu | 516-367-5045
Cancer cells achieve their pathogenicity by changing which genes are on and off. To maintain these changes in gene expression, cancer cells rely on proteins that interact with DNA or modify chromatin. My group investigates how such factors sustain the aberrant capabilities of cancer cells, thereby identifying new therapeutic targets.
Cancer can be understood as a disease of dysfunctional gene expression control. Research in Chris Vakoc’s lab investigates how transcription factors and chromatin regulators cooperate to control gene expression and maintain the cancer cell state. This work makes extensive use of genetic screens to reveal cancer-specific functions for transcriptional regulators, as well as genomic and biochemical approaches to identify molecular mechanisms. One theme that has emerged from their efforts is that blood cancers are often vulnerable to targeting transcriptional coactivators, such as BRD4 and the SWI/SNF chromatin remodeling complex. Vakoc’s team demonstrated that chemical inhibition of BRD4 exhibits therapeutic effects in mouse models of leukemia, a finding that has motivated ongoing clinical trials in human leukemia patients. The Vakoc lab has also developed a CRISPR-Cas9 screening approach that can reveal individual protein domains that sustain cancer cells. Their lab is now deploying this technology in a diverse array of human cancers to reveal therapeutic opportunities and basic mechanisms of cancer gene control.
Vakoc wins Paul Marks Prize for cancer research
AACR Outstanding Achievement in Cancer Research Award
Forbeck Scholar Award
"V Scholar" by The V Foundation for Cancer Research
Burroughs Welcome Fund Career Award for Medical Scientists
Pershing Square Sohn Prize
Leukemia and Lymphoma Society Scholar Award
‘Her dream continues’
February 7, 2025
A night of remembrance, a generous donation, and another step closer to a cancer-free world.
Cocktails & Chromosomes: Cancer’s identity crisis
December 19, 2024
CSHL Professor Christopher Vakoc shares his research with a standing-room-only crowd at Industry bar in Huntington, NY.
Flipping cancer’s off switch
November 7, 2024
CSHL Professor Christopher Vakoc and postdoc Olaf Klingbeil have found a potential drug target for some of the most common and deadly cancers.
Friends of T.J. Foundation carries on his legacy
October 18, 2024
Since 2014, the organization has donated more than $500,000 in support of Cold Spring Harbor Laboratory’s cancer research.
At the Lab Season 1 Research Rewind: Cancer
October 8, 2024
As the first season of our new podcast winds down, we’re revisiting all of our episodes with a focus on CSHL’s cutting-edge cancer research.
At the Lab Episode 22: Outmuscling cancer
September 3, 2024
After 10 years, CSHL has made a breakthrough in the study of RMS, a rare pediatric cancer. How we got here is a story of innovation and perseverance.
Pancreatic cancer’s cellular amnesia
June 17, 2024
New study from CSHL Professor Christopher Vakoc and former postdoc Diogo Maia-Silva shows how basal-like cancer cells lose their original identity.
The immune system’s moonlighters
February 20, 2024
A tiny protein sequence with the potential to unlock new therapies against autoimmune diseases has been hiding in plain sight— until now.
Pancreatic cancer hijacks a brain-building protein
February 14, 2024
CSHL researchers have found that EN-1, a protein involved in neurodevelopment, can help pancreatic cancer spread throughout the body.
Angel’s Wish raises $45K for CSHL cancer research
February 7, 2024
The Christina Renna Foundation’s generous gift supports Professor Christopher Vakoc’s pioneering sarcoma research.
All Publications
Histone chaperones coupled to DNA replication and transcription control divergent chromatin elements to maintain cell fate
16 Apr 2025 | Genes & Development
Franklin, Reuben; Zhang, Brian; Frazier, Jonah; Chen, Meijuan; Do, Brian; Padayao, Sally; Wu, Kun; Vander Heiden, Matthew; Vakoc, Christopher; Roe, Jae-Seok; Ninova, Maria; Murn, Jernej; Sykes, David; Cheloufi, Sihem;
PKM splice-switching ASOs induce upregulation of dual-specificity phosphatases and dephosphorylation of ERK1/2 in hepatocellular carcinoma
22 Feb 2025 | Journal of Biological Chemistry | :108345
Voss, Dillon; Kral, Alexander; Sim, GeunYoung; Utama, Raditya; Lin, Kuan-Ting; Cizmeciyan, Chris; Schafer, Balazs; Cunniff, Patrick; Vakoc, Christopher; Caruthers, Marvin; Mishra, Lopa; Krainer, Adrian;
Sequential epigenetic therapy in AML
13 Feb 2025 | Blood | 145(7):660-661
Wang, Yuanting; Vakoc, Christopher;
PTPN23-dependent ESCRT machinery functions as a cell death checkpoint
28 Nov 2024 | Nature Communications | 15(1):10364
Song, Dongyan; Cen, Yuxin; Qian, Zhe; Wu, Xiaoli; Rivera, Keith; Wee, Tse-Luen; Demerdash, Osama; Chang, Kenneth; Pappin, Darryl; Vakoc, Christopher; Tonks, Nicholas;
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function
25 Oct 2024 | Science | 386(6720):eadk9167
Swamynathan, Manojit; Kuang, Shan; Watrud, Kaitlin; Doherty, Mary; Gineste, Charlotte; Mathew, Grinu; Gong, Grace; Cox, Hilary; Cheng, Eileen; Reiss, David; Kendall, Jude; Ghosh, Diya; Reczek, Colleen; Zhao, Xiang; Herzka, Tali; Špokaitė, Saulė; Dessus, Antoine; Kim, Seung; Klingbeil, Olaf; Liu, Juan; Nowak, Dawid; Alsudani, Habeeb; Wee, Tse-Luen; Park, Youngkyu; Minicozzi, Francesca; Rivera, Keith; Almeida, Ana; Chang, Kenneth; Chakrabarty, Ram; Wilkinson, John; Gimotty, Phyllis; Diermeier, Sarah; Egeblad, Mikala; Vakoc, Christopher; Locasale, Jason; Chandel, Navdeep; Janowitz, Tobias; Hicks, James; Wigler, Michael; Pappin, Darryl; Williams, Roger; Cifani, Paolo; Tuveson, David; Laporte, Jocelyn; Trotman, Lloyd;
JMJD1C forms condensates to facilitate a RUNX1-dependent gene expression program shared by multiple types of AML cells
25 Oct 2024 | Protein and Cell | :pwae059
Chen, Qian; Wang, Saisai; Zhang, Juqing; Xie, Min; Lu, Bin; He, Jie; Zhen, Zhuoran; Li, Jing; Zhu, Jiajun; Li, Rong; Li, Pilong; Wang, Haifeng; Vakoc, Christopher; Roeder, Robert; Chen, Mo;
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks
6 Aug 2024 | Cell Death Discovery | 10(1):351
Cassandri, Matteo; Porrazzo, Antonella; Pomella, Silvia; Noce, Beatrice; Zwergel, Clemens; Aiello, Francesca; Vulcano, Francesca; Milazzo, Luisa; Camero, Simona; Pajalunga, Deborah; Spada, Massimo; Manzi, Valeria; Gravina, Giovanni; Codenotti, Silvia; Piccione, Michela; Tomaciello, Miriam; Signore, Michele; Barillari, Giovanni; Marchese, Cinzia; Fanzani, Alessandro; De Angelis, Biagio; Quintarelli, Concetta; Vakoc, Christopher; Chen, Eleanor; Megiorni, Francesca; Locatelli, Franco; Valente, Sergio; Mai, Antonello; Rota, Rossella; Marampon, Francesco;
MARK2/MARK3 kinases are catalytic co-dependencies of YAP/TAZ in human cancer
26 Jul 2024 | Cancer Discovery
Klingbeil, Olaf; Skopelitis, Damianos; Tonelli, Claudia; Yoshimoto, Toyoki; Alpsoy, Aktan; Panepinto, Maria; Minicozzi, Francesca; Merrill, Joseph; Cafiero, Amanda; Aggarwal, Disha; Russo, Suzanne; Ha, Taehoon; Demerdash, Osama; Wee, Tse-Luen; Spector, David; Lyons, Scott; Tuveson, David; Cifani, Paolo; Vakoc, Christopher;
Mammalian SWI/SNF complex activity regulates POU2F3 and constitutes a targetable dependency in small cell lung cancer
17 Jul 2024 | Cancer Cell | :S1535-6108(24)00237
Duplaquet, Leslie; So, Kevin; Ying, Alexander; Pal Choudhuri, Shreoshi; Li, Xinyue; Xu, Grace; Li, Yixiang; Qiu, Xintao; Li, Rong; Singh, Shilpa; Wu, Xiaoli; Hamilton, Seth; Chien, Victor; Liu, Qi; Qi, Jun; Somerville, Tim; Heiling, Hillary; Mazzola, Emanuele; Lee, Yenarae; Zoller, Thomas; Vakoc, Christopher; Doench, John; Forrester, William; Abrams, Tinya; Long, Henry; Niederst, Matthew; Drapkin, Benjamin; Kadoch, Cigall; Oser, Matthew;
A ΔNp63–MED12 axis drives basal-like identity in pancreatic cancer
Jul 2024 | Nature Genetics | 56(7):1331-1332
Maia-Silva, Diogo; Vakoc, C;